191 related articles for article (PubMed ID: 19142743)
1. Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection.
Nafar M; Farrokhi F; Vaezi M; Entezari AE; Pour-Reza-Gholi F; Firoozan A; Eniollahi B
Int Urol Nephrol; 2009; 41(3):687-93. PubMed ID: 19142743
[TBL] [Abstract][Full Text] [Related]
2. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
[TBL] [Abstract][Full Text] [Related]
3. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
4. High pre-transplant soluble CD30 levels are predictive of the grade of rejection.
Rajakariar R; Jivanji N; Varagunam M; Rafiq M; Gupta A; Sheaff M; Sinnott P; Yaqoob MM
Am J Transplant; 2005 Aug; 5(8):1922-5. PubMed ID: 15996240
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure?
de Holanda MI; Matuck T; de Carvalho DDBM; Domingues EMFL; Curvo R; Glasberg DS; Santos AMG; Borela ÁM; Pôrto LC
Transplant Proc; 2018 Apr; 50(3):728-736. PubMed ID: 29661425
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
[TBL] [Abstract][Full Text] [Related]
7. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
Dong W; Shunliang Y; Weizhen W; Qinghua W; Zhangxin Z; Jianming T; He W
Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
10. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
12. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
[TBL] [Abstract][Full Text] [Related]
13. [Combined assay of soluble CD30 and hepatocyte growth factor for diagnosis of acute renal allograft rejection].
Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; Du CF; Wang YB
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):241-2. PubMed ID: 18250052
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
Platt RE; Wu KS; Poole K; Newstead CG; Clark B
J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
16. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
[TBL] [Abstract][Full Text] [Related]
17. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
Wang D; Wu W; Yang S; Wang Q; Tan J
Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis.
Mirzakhani M; Shahbazi M; Akbari R; Dedinská I; Nemati E; Mohammadnia-Afrouzi M
Front Immunol; 2020; 11():295. PubMed ID: 32256486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
